Bloodstream Infections in Patients With Rheumatoid Arthritis
NCT03908086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000000
Last updated 2019-04-09
Summary
Study of incidence and risk factors of staphylococcus aureus bacteremia in patients with rheumatoid arthritis compared with the general population in a nationwide cohort of all adult members of the population from 1996 until 2017 using national registries
Conditions
- Rheumatoid Arthritis
- Staphylococcus Aureus Bacteremia
Interventions
- OTHER
-
Risk factors in RA cohort
- OTHER
-
Risk factors in general population
Sponsors & Collaborators
-
University of Copenhagen
collaborator OTHER -
University of Aarhus
collaborator OTHER -
Statens Serum Institut
collaborator OTHER -
Sabine Dieperink
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-12-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
More Related Trials
-
A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
NCT04115423 ·Status: UNKNOWN
-
Study of the Articular Microbiota in Rheumatoid Arthritis.
NCT04056234 ·Status: COMPLETED
-
A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
NCT03882008 ·Status: COMPLETED ·Phase: PHASE4
-
COVID-SErology in Rheumatoid Arthritis (COVID-19)
NCT04407559 ·Status: COMPLETED
-
A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis
NCT01665430 ·Status: TERMINATED ·Phase: PHASE3
-
A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting
NCT05487703 ·Status: COMPLETED
-
A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid Arthritis
NCT01209585 ·Status: COMPLETED
-
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
NCT01063803 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
NCT00282308 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis
NCT04721808 ·Status: COMPLETED
-
A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis
NCT01655381 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs
NCT04530682 ·Status: COMPLETED
-
A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis
NCT00380744 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
COVID-19 Vaccination in Rheumatic Disease Patients
NCT04839315 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
NCT07201558 ·Status: RECRUITING ·Phase: PHASE1
-
A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis
NCT00721123 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
NCT02557100 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis
NCT06933134 ·Status: RECRUITING
-
A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)
NCT01668966 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Factors for COVID-19 in Rheumatology
NCT04567576 ·Status: UNKNOWN
-
Purify Antigen-specific B Cells From Patients With Rheumatoid Arthritis
NCT05203952 ·Status: UNKNOWN
-
An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis
NCT01664598 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tocilizumab in Patients With Rheumatoid Arthritis
NCT01187563 ·Status: COMPLETED
-
Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine
NCT01980836 ·Status: UNKNOWN ·Phase: PHASE4
-
Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis
NCT04842981 ·Status: TERMINATED ·Phase: PHASE1/PHASE2